BioScrip sales increase, profits decrease in Q3
ELMSFORD, N.Y. — Specialty pharmacy provider BioScrip reported $454 million in sales and $500,000 in profits in third quarter 2011, according to an earnings statement released Tuesday.
The sales figure represented a 2.9% increase over third quarter 2010's $441.2 million, while the profits compared with profits of $2 million during the same period a year ago.
"Overall, growth occurred in spite of a challenging economic environment impacting demand for services, lower acuity levels, shifts in reimbursement rates and other short-term trends impacting companies industry wide," BioScrip president and CEO Rick Smith said. "The diversification that we have in our payer mix has enabled us to keep making forward progress."